Authors
Latest:
The Future of AI in Dermatology with Andy Beck, MD, PhDThe co-founder of PathAI and its PathAssist Derm tool believes AI is going to be incredibly valuable for dermatologists and dermatopathologists.
Latest:
Biosimilars Offer VA Cost Savings in Psoriasis TreatmentEnhanced education can reduce uncertainty among both patients and providers, with pharmacists playing a key role as primary sources of patient information.
Latest:
Beyond Melasma: Systemic Causes of Facial HyperpigmentationFacial hyperpigmentation may signal systemic disease. Dermatologists must assess beyond melasma to ensure timely, accurate diagnosis and care.
Latest:
Iain Stuart, PhD: VYN202 Positive Safety and Tolerability in Phase 1aVYNE recently announced positive results for its novel oral small molecule BD2-selective BET inhibitor in a single-ascending dose clinical trial.
Latest:
FDA Grants Fast Track Designation to Nemvaleukin Alfa for Mucosal MelanomaImmunotherapy agent nemvaleukin alfa was granted an FDA fast track designation for the treatment of patient’s mucosal melanoma for previously undergone treatment with an anti-PD-L1 therapy.
Latest:
How Can Patients Benefit From New Device, TruFacial?Founder Dina El-Sherif, MBA, gave an in-depth overview of the at-home facial rejuvenation device and its 3-step process at AAD 2024.
Latest:
How Emerging Therapies Are Changing the AD Treatment LandscapeMany patients with severe AD are unaware of newer, more effective treatments.
Latest:
Michael Gold, MD: Advances in Acne Treatment and Energy-Based DevicesGold highlighted the growing role of energy-based devices in acne treatment during his AAD session.
Latest:
What’s Next for ET-02? CEO of Eirion, Jon Edelson, MD, Shares Phase 2 Plans“As good as we saw results in 1 month, we think we'll see even more remarkable results over the 6 months of treatment,” Edelson said in an interview with Dermatology Times.
Latest:
An Overview of Pediatric PsoriasisIn one-third of cases of psoriasis, disease onset occurs in the first or second decade of life, although it may not be diagnosed until the patient has reached adulthood.
Latest:
Unmet Needs in the Treatment of Atopic DermatitisDiego Ruiz Dasilva, MD, FAAD, reviews the unmet needs and barriers in the treatment landscape of atopic dermatitis.
Latest:
Acne vulgaris in teenagersIt effects most teenagers and can lead to mental distress. Here are 5 important facts about acne vulgaris in adolescents.
Latest:
Sexual and Gender Minority Patients With Chronic Inflammatory Skin Diseases Affected by Obstacles to CareSexual and gender minority patients with chronic inflammatory skin diseases may be disproportionately influenced by cost and noncost obstacles to health care.
Latest:
Considerations to Best Serve Transgender Patients Seeking Aesthetic CareRonda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.
Latest:
Q+A: Roflumilast cream 0.15% for AD with Eric Simpson, MD, MCR, FAADEric Simpson, MD, MCR, FAAD, lead author of a recently-published article highlighting roflumilast cream 0.15%, joined us for a Q+A interview.
Latest:
Cannabis Extract PHEC-66 Triggers Cell Death in Melanoma, Study DemonstratesResearchers sought to expand knowledge of the role of cannabis and its molecular mechanisms in anticancer effects.
Latest:
Addressing Unmet Needs Globally: LEO Pharma’s Commitment to DermatologyChristophe Bourdon, CEO, discusses LEO Pharma's groundbreaking presentations at EADV, delgocitinib's US pending approval, and the company's commitment to addressing chronic hand eczema.
Latest:
Choosing a Biologic in Psoriasis With Ahmad Amin, MD, FAADAhmad Amin, MD, FAAD, reviews biologic selection in patients with psoriatic disease.
Latest:
Is OX40 Inhibition the Next Game Changer for Atopic Dermatitis?Learn more about the OX40-OX40L pathway and 2 drugs heading toward phase 3 trials.
Latest:
We are Biologic Coordinators of Dermatology (BCoD)Explore how BCs are supported through complex drug approvals and ensuring patients have access to prescribed medications.
Latest:
Nailing Common, Rare, and Scary Pediatric Nail Conditions and SurgeriesJane Bellet, MD, will present 2 sessions full of pearls to ensure tiny fingers and toes are cared for in a timely, heartfelt, and effective treatment regimen.
Latest:
AAD, Janssen, and Kenvue Partner to Mentor Next Generation of DermatologistsDaphne Chan, PhD, MHEcon, discusses the Pathways program, a partnership between the AAD, Janssen, and Kenvue to mentor young, aspiring dermatology providers.
Latest:
Study Reveals Majority of US Adults Distrust Health Care System’s Use of AIA study found that 65.8% of US adults distrust their health care system’s use of AI, highlighting a need for better communication on AI tools.
Latest:
Celebrating Women’s History Month with Mindy Haws, MD, and the LIMITLESS Initiative“It's so exciting to see all these incredible female talents behind me. I want to give back and I want to help them climb on my shoulders and go higher,” Haws said.
Latest:
Current Unmet Needs and Emerging Solutions in Atopic Dermatitis ManagementAlexandra Golant, MD discusses how addressing severe, recalcitrant atopic dermatitis remains the most pressing unmet need, with emerging biologics, oral JAK inhibitors, and combination therapies offering promising new approaches for these challenging cases.
Latest:
Tackling Unmet Needs in Dermatology With RezpegaldesleukinJonathan Zalevsky, PhD, discusses the unmet needs in atopic dermatitis treatment, the potential of Rezpeg, and the importance of novel therapies.
